Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
4
Lantheus
LNTH
5
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
AXSM Axsome Therapeutics
- 111.210
- +3.970+3.70%
Trading Apr 29 12:34 ET
5.42BMarket Cap-18.57P/E (TTM)
111.210High107.215Low209.22KVolume107.615Open107.240Pre Close22.94MTurnover0.57%Turnover RatioLossP/E (Static)48.77MShares139.13052wk High95.13P/B4.08BFloat Cap64.11052wk Low--Dividend TTM36.67MShs Float139.130Historical High--Div YieldTTM3.73%Amplitude1.940Historical Low109.631Avg Price1Lot Size
Axsome Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 11.49%-128.41M | 13.70%-26.2M | 65.21%-18.63M | 45.60%-30.11M | -818.52%-53.47M | -24.52%-145.08M | -10.15%-30.36M | -135.29%-53.55M | -65.04%-55.35M | 82.17%-5.82M |
| Net income from continuing operations | -20.05%-287.22M | 24.06%-74.91M | -3.86%-64.6M | -18.13%-79.35M | -509.35%-68.36M | -27.84%-239.24M | -61.09%-98.65M | -38.77%-62.2M | -62.09%-67.17M | 71.69%-11.22M |
| Depreciation and amortization | 16.45%7.96M | 19.14%2.07M | 18.24%2.06M | 18.00%1.99M | 10.17%1.83M | 55.25%6.83M | 2.84%1.74M | 3.75%1.74M | 135.24%1.69M | 432.69%1.66M |
| Other non cash items | -40.24%31.73M | -73.19%11.85M | 1,572.14%17.22M | -59.95%2.98M | -177.33%-324K | 1,000.44%53.1M | 878.29%44.21M | 156.22%1.03M | 7,251.92%7.44M | 5,137.50%419K |
| Change In working capital | 219.40%33.9M | 273.69%12.8M | 156.09%5.03M | 272.97%22.88M | 29.29%-6.81M | -219.95%-28.39M | -79.49%3.43M | -183.10%-8.96M | -360.26%-13.23M | -925.24%-9.63M |
| -Change in receivables | 17.40%-47.18M | -9.14%-17.91M | 65.89%-3.75M | 16.40%-18.91M | 6.75%-6.62M | -51.52%-57.12M | 5.70%-16.41M | -166.21%-11.01M | -39.89%-22.62M | ---7.09M |
| -Change in inventory | 45.34%-2.44M | -130.81%-4.14M | -23.45%2.15M | 150.19%528K | 78.01%-972K | 15.41%-4.46M | 60.45%-1.8M | 438.89%2.81M | -1,243.48%-1.05M | ---4.42M |
| -Change in prepaid assets | 27.59%-3.86M | 208.81%1.43M | -80.52%-1.6M | 131.55%224K | -61.86%-3.92M | -95.06%-5.34M | -307.74%-1.32M | 26.49%-888K | -181.33%-710K | -16.51%-2.42M |
| -Change in payables and accrued expense | 126.82%87.38M | 45.65%33.41M | 6,488.80%8.24M | 268.00%41.04M | 9.03%4.7M | -44.47%38.53M | -41.11%22.94M | -99.26%125K | -9.55%11.15M | 278.56%4.31M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 11.49%-128.41M | 13.70%-26.2M | 65.21%-18.63M | 45.60%-30.11M | -818.52%-53.47M | -24.52%-145.08M | -10.15%-30.36M | -135.29%-53.55M | -65.04%-55.35M | 82.17%-5.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 53.61%-270K | -328.57%-30K | 75.74%-90K | 60.90%-52K | -38.03%-98K | 98.92%-582K | 96.13%-7K | -462.12%-371K | 99.75%-133K | 66.82%-71K |
| Net PPE purchase and sale | 53.61%-270K | -328.57%-30K | 75.74%-90K | 60.90%-52K | -38.03%-98K | 17.09%-582K | 96.13%-7K | -462.12%-371K | 44.81%-133K | 66.82%-71K |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 53.61%-270K | -328.57%-30K | 75.74%-90K | 60.90%-52K | -38.03%-98K | 98.92%-582K | 96.13%-7K | -462.12%-371K | 99.75%-133K | 66.82%-71K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -82.53%57.84M | 712,300.00%14.24M | -8.89%30.41M | -94.16%14.38M | -102.30%-1.19M | 16.32%331.01M | -100.19%-2K | -81.14%33.37M | 226.09%246.08M | 65.79%51.57M |
| Net issuance payments of debt | -101.16%-990K | ---330K | ---311K | -100.62%-186K | -100.30%-163K | 88.89%85M | --0 | --0 | -33.33%30M | --55M |
| Net common stock issuance | -84.24%40.78M | --16.42M | -61.18%13.1M | ---- | ---- | 6.15%258.75M | --0 | -81.27%33.75M | ---- | ---- |
| Proceeds from stock option exercised by employees | 147.04%30.68M | 0.26%1.15M | 370.00%20.29M | 2.60%6.74M | 546.25%2.5M | 98.67%12.42M | -59.53%1.15M | 40.89%4.32M | 3,632.95%6.57M | 112.64%387K |
| Net other financing activities | 49.78%-12.63M | -160.94%-2.99M | 43.05%-2.68M | 77.79%-3.44M | 7.77%-3.53M | -141.14%-25.16M | 34.94%-1.15M | 25.65%-4.7M | -584.49%-15.49M | -4,194.38%-3.82M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -82.53%57.84M | 712,300.00%14.24M | -8.89%30.41M | -94.16%14.38M | -102.30%-1.19M | 16.32%331.01M | -100.19%-2K | -81.14%33.37M | 226.09%246.08M | 65.79%51.57M |
| Net cash flow | ||||||||||
| Beginning cash position | 92.29%386.19M | -21.42%327.34M | -27.79%315.66M | 34.45%331.44M | 92.29%386.19M | 132.26%200.84M | 83.09%416.56M | 495.57%437.11M | 191.02%246.52M | 132.26%200.84M |
| Current changes in cash | -138.22%-70.84M | 60.53%-11.99M | 156.86%11.68M | -108.28%-15.78M | -219.88%-54.75M | 62.06%185.35M | -13.84%-30.37M | -113.33%-20.55M | 1,784.62%190.6M | 2,687.71%45.67M |
| End cash Position | -18.34%315.35M | -18.34%315.35M | -21.42%327.34M | -27.79%315.66M | 34.45%331.44M | 92.29%386.19M | 92.29%386.19M | 83.09%416.56M | 495.57%437.11M | 191.02%246.52M |
| Free cash flow | 11.66%-128.68M | 13.62%-26.23M | 65.28%-18.72M | 45.64%-30.16M | -809.11%-53.57M | -24.27%-145.66M | -9.46%-30.37M | -136.24%-53.92M | -64.25%-55.48M | 82.07%-5.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀